🔎 Trials Near Me

Home › Breast Cancer › Michigan › Warren

Breast Cancer clinical trials in Warren, MI

9 studies for Breast Cancer are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Madison Heights Hospital - Breast, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • and 9 more
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

RecruitingPhase 3
  • Profound Research LLC at Michigan Hematology and Oncology Consultants, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07173751

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

RecruitingPhase 1
  • Profound Research LLC at Michigan Hematology and Oncology Consultants, Royal Oak · 7 mi away
Ages 18 to 55 · Women · Updated Sep 9, 2026 · NCT07310420

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

RecruitingPhase 3
  • Profound Research LLC, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06982521

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome
  • Henry Ford Medical Center - Royal Oak, Royal Oak · 7 mi away
  • Henry Ford Medical Center-Cottage, Grosse Pointe Farms · 8 mi away
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

RecruitingPhase 3
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Madison Heights Hospital - Breast, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • and 3 more
Ages 18 to 60 · Women · Updated Sep 2, 2026 · NCT05879926

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RecruitingPhase 3
  • Henry Ford Health Warren Hospital, Warren
  • Michigan Healthcare Professionals Madison Heights, Madison Heights · 5 mi away
  • Corewell Health William Beaumont University Hospital, Royal Oak · 7 mi away
Ages 50 to 70 · All sexes · Updated Apr 23, 2026 · NCT04852887

Quantitative MRI Assessment of Breast Cancer Therapy Response

RecruitingObservational study
  • Corewell Health William Beaumont University Hospital, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT05704062

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

RecruitingObservational study
  • St. John Hospital, Grosse Pointe Woods · 6 mi away
  • Beaumont Breast Care Center, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Aug 20, 2025 · NCT03053193

About Breast Cancer

Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.

More about Breast Cancer on MedlinePlus

Breast Cancer trials in other cities

Other studies in Warren

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.